Sign in

    Ali Strickland

    Research Analyst at Baird

    Ali Strickland is an Equity Research Analyst at Baird specializing in the coverage of the MedTech and Diagnostics sector, where she covers companies such as Agilent Technologies, Danaher Corporation, and Thermo Fisher Scientific. She has developed a reputation for thoughtful stock recommendations and in-depth industry analysis, with her calls tracked on performance platforms like TipRanks and consistently generating above-benchmark returns and a success rate close to 60%. Ali began her career in equity research at Baird after graduating from a top business school, progressing rapidly within the firm to her current role. She holds a Series 7 and Series 63 registration with FINRA, reflecting her professional commitment and regulatory qualifications in investment analysis.

    Ali Strickland's questions to OneWater Marine (ONEW) leadership

    Ali Strickland's questions to OneWater Marine (ONEW) leadership • Q1 2025

    Question

    Ali Strickland of Baird asked about the mix of first-time versus trade-in buyers, the drivers behind increased F&I penetration, and the current M&A pipeline.

    Answer

    President/COO Anthony Aisquith and CFO Jack Ezzell confirmed that trade-ins are increasing, with trades up double-digits. CEO Philip Singleton added that changes in state titling laws are also pushing more trades through dealerships. On F&I, Ezzell attributed higher penetration to a concerted team effort and special financing on discontinued brands. Regarding M&A, Singleton stated the company is in 'no hurry' and will remain selective and disciplined on timing.

    Ask Fintool Equity Research AI